Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling

Human Pathology

Volumn 33, Issue 9, 2002, Pages 871-876

  Torbenson, Michael ^a,b   Marinopoulos, Spyridon ^a,b   Dang, Duyen T ^a,b   Choti, Michael ^a,b   Ashfaq, Raheela ^a,b   Maitra, Anirban ^a,b   Boitnott, John ^a,b   Wilentz, Robb E ^a,b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Hepatic adenoma; Hepatocellular carcinoma; Smad4; TGF II receptor

Indexed keywords

SMAD PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ALCOHOL LIVER DISEASE; ANTIBODY LABELING; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FATTY LIVER; FEMALE; GENE OVEREXPRESSION; HEMOCHROMATOSIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MITOSIS; TUMOR SUPPRESSOR GENE;

EID: 0036742790     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2002.128061     Document Type: Article

References (41)

1. Rossmanith W, Schulte-Hermann R: Biology of transforming growth factor beta in hepatocarcinogenesis. Microsc Res Tech 52:430-436, 2001
2. Hahn SA, Hoque AT, Moskaluk CA, et al: Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res 56:490-494, 1996
3. Hahn SA, Schutte M, Hoque AT, et al: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353, 1996
4. Argani P, Shaukat A, Kaushal M, et al: Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts. Cancer 91:1332-1341, 2001
5. Lei J, Zou TT, Shi YQ, et al: Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms. Oncogene 13:2459-2462, 1996
6. Maitra A, Molberg K, Albores-Saavedra J, et al: Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease. Am J Pathol 157:1105-1111, 2000
7. Schutte M, Hruban RH, Hedrick L, et al: DPC4 gene in various tumor types. Cancer Res 56:2527-2530, 1996
8. Kawate S, Takenoshita S, Ohwada S, et al: Mutation analysis of transforming growth factor beta type II receptor, Smad2, and Smad4 in hepatocellular carcinoma. Int J Oncol 14:127-131, 1999
9. Yakicier MC, Irmak MB, Romano A, et al: Smad2 and Smad4 gene mutations in hepatocellular carcinoma. Oncogene 18:4879-4883, 1999
10. Wilentz RE, Su GH, Dai JL, et al: Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreatic adenocarcinomas: A new marker of Dpc4 inactivation. Am J Pathol 156:37-43, 2000
11. Shirota Y, Kaneko S, Honda M, et al: Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays. Hepatology 33:832-840, 2001
12. Xu XR, Huang J, Xu ZG, et al: Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci U S A 98:15089-15094, 2001
13. Rooke HM, Crosier KE: The Smad proteins and TGF-β signalling: Uncovering a pathway critical in cancer. Pathology 33:73-84, 2001
14. Tambur AR, Ortegel JW, Ben-Ari Z, et al: Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients. Transplantation 71:1475-1480, 2001
15. Nzeako UC, Goodman ZD, Ishak KG: Comparison of tumor pathology with duration of survival of North American patients with hepatocellular carcinoma. Cancer 76:579-588, 1995
16. Ishak K, Baptista A, Bianchi L, et al: Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699, 1995
17. Kiss A, Wang NJ, Xie JP, et al: Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth factor/c-met, TGF-β receptor type II, and p53 expression in human hepatocellular carcinomas. Clin Cancer Res 3:1059-1066, 1997
18. Ueno T, Hashimoto O, Kimura R, et al: Relation of type II transforming growth factor-beta receptor to hepatic fibrosis and hepatocellular carcinoma. Int J Oncol 18:49-55, 2001
19. Wong SF, Lai LC: The role of TGF-β in human cancers. Pathology 33:85-92, 2001
20. Reynisdottir I, Polyak K, Iavarone A, et al: Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev 9:1831-1845, 1995
21. Hannon GJ, Beach D: p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371:257-261, 1994
22. Sugiyama A, Nagaki M, Shidoji Y, et al: Regulation of cell cycle-related genes in rat hepatocytes by transforming growth factor beta-I. Biochem Biophys Res Commun 238:539-543, 1997
23. Xu L, Hui L, Wang S, et al: Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res 61:3176-3181, 2001
24. Takeo S, Arai H, Kusano N, et al: Examination of oncogene amplification by genomic DNA microarray in hepatocellular carcinomas: Comparison with comparative genomic hybridization analysis. Cancer Genet Cytogenet 130:127-132, 2001
25. Tackels-Horne D, Goodman MD, Williams AJ, et al: Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling. Cancer 92:395-405, 2001
26. Okabe H, Satoh S, Kato T, et al: Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: Identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 61:2129-2137, 2001
27. Lau WY, Lai PB, Leung MF, et al: Differential gene expression of hepatocellular carcinoma using cDNA microarray analysis. Oncol Res 12:59-69, 2000
28. Graveel CR, Jatkoe T, Madore SJ, et al: Expression profiling and identification of novel genes in hepatocellular carcinomas. Oncogene 20:2704-2712, 2001
29. Kim MY, Park E, Park JH, et al: Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas. Oncogene 20:4568-4575, 2001
30. Yamashita T, Kaneko S, Hashimoto S, et al: Serial analysis of gene expression in chronic hepatitis C and hepatocellular carcinoma. Biochem Biophys Res Commun 282:647-654, 2001
31. Lee DK, Park SH, Yi Y, et al: The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: Potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev 15:455-466, 2001
32. Bedossa P, Peltier E, Terris B, et al: Transforming growth factor-beta 1 (TGF-β 1) and TGF-β 1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology 21:760-766, 1995
33. Abou-Shady M, Baer HU, Friess H, et al: Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma. Am J Surg 177:209-215, 1999
34. Sue SR, Chari RS, Kong FM, et al: Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Ann Surg 222:171-178, 1995
35. Orsatti G, Hytiroglou P, Thung SN, et al: Lamellar fibrosis in the fibrolamellar variant of hepatocellular carcinoma: A role for transforming growth factor beta. Liver 17:152-156, 1997
36. Torbenson M, Lee JH, Choti M, et al: Hepatic adenomas: Analysis of sex steroid receptor status and the wnt signaling pathway. Mod Pathol 15:189-196, 2002
37. Chen T, Carter D, Garrigue-Antar L, et al: Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer. Cancer Res 58:4805-4810, 1998
38. Oft M, Heider KH, Beug H: TGF-β signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 8:1243-1252, 1998
39. Anzano MA, Roberts AB, De Larco JE, et al: Increased secretion of type beta transforming growth factor accompanies viral transformation of cells. Mol Cell Biol 5:242-247, 1985
40. Ito N, Kawata S, Tamura S, et al: Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer Res 51:4080-4083, 1991
41. Matsuzaki K, Date M, Furukawa F, et al: Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: Implications for roles of Smads in its growth. Hepatology, 32:218-227, 2000